Balsm Alofoq Medical Co. (9620.SR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Balsm Alofoq Medical Co., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Valuation | ||||
| P/E Ratio | 34.50x | 15.81x | 18.02x | 21.35x |
| P/B Ratio | 2.20x | 2.61x | 5.21x | 10.19x |
| P/S Ratio | 3.33x | 3.81x | 4.16x | 4.41x |
| Profitability | ||||
| Gross Margin | 38.2% | 47.3% | 44.3% | 48.0% |
| Operating Margin | 12.6% | 23.9% | 22.9% | 21.9% |
| Net Margin | 9.7% | 24.1% | 23.1% | 20.7% |
| EBITDA Margin | 12.6% | 23.9% | 31.3% | 30.6% |
| Liquidity | ||||
| Current Ratio | 10.26x | 12.94x | 3.81x | 1.69x |
| Quick Ratio | 8.21x | 11.89x | 2.82x | 1.40x |
| Leverage | ||||
| Debt/Equity | 0.05x | 0.06x | 0.13x | 0.36x |
YoY = year-over-year change. Source: FMP..